查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375993

血液筛检市场规模、份额、趋势分析报告：按技术、按产品、按地区、细分市场趋势，2023-2030 年

Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

血液筛检市场的成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球血液筛检市场预计将达到66.2亿美元，2023年至2030年的年复合成长率为11.7%。

市场的成长归因于捐赠者筛选的增加和市场参与企业不断的技术进步。由于捐血的增加、对输血感染疾病的认识的提高以及行业技术的发展，对血液筛检测试的需求持续增加。此外，各国政府要求对所有捐血的血液进行多种病毒检测。

需要对所有捐血的血液进行彻底筛检，以确保接受者获得最安全的血液製品。截至 2015 年，此类检测包括筛检红血球抗体和感染疾病病原体：HIV-1、HIV-2、肝炎病毒、西尼罗河病毒 (WNV)、人类 T 淋巴细胞病毒 (HTLV)、T. Cruzi，T. pallidum（梅毒）。捐血的一个条件是所有这些测试结果均为阴性。

技术的发展正在提高测试的灵敏度和效率。例如，2016 年，美国FDA核准了Hologic, Inc. 和 Grifols 的 Procleix 寨卡病毒检测方法，用于筛检捐血的血液。此外，美国FDA 于 2013 年核准了下一代定序 (NGS) 技术。该技术比传统 DNA 分析方法更便宜、更快速。

血液筛检市场报告亮点

  • 2022年，试剂细分市场占据最大收益占有率，约73.0%，预计在预测期内将以12.0%的最快年复合成长率成长。
  • 北美地区主导市场，2022 年收益占有率最大，为 39.0%。这是由于主要行业参与者的存在、血液筛检流程的日益采用、FDA 对输血的严格法规、感染疾病爆发的增加以及患者的高经济负担，这些因素将在预测期内保持其地位。因素。
  • 由于捐血意识的提高、患者经济负担的增加以及主要行业参与者对新兴国家的关注，预计亚太地区在预测期内将以 13.5% 的年复合成长率增长最快。

目录

第1章调查方法和范围

第2章执行摘要

第3章血液筛检市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 血液筛检市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章血液筛检市场：技术评估与趋势分析

  • 血液筛检市场：重点
  • 血液筛检市场：2022 年和 2030 年趋势和市场占有率分析
  • 核酸扩增（NAT）
  • ELISA
  • 化学冷光免疫检测（CLIA）和酵素免疫分析法（EIA）
  • 下一代定序
  • 蛋白质印迹法

第5章血液筛检市场：产品评估与趋势分析

  • 血液筛检市场：重点
  • 血液筛检市场：2022 年和 2030 年趋势和市场占有率分析
  • 试剂
  • 装置

第6章血液筛检市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的血液筛检市场：重点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott
    • Danaher Corporation (Beckman Coulter)
    • Bio-Rad Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Grifols, SA
    • Ortho-Clinical Diagnostics, Inc.
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific, Inc.
    • SOFINA sa (Biomerieux)
Product Code: GVR-1-68038-215-0

Blood Screening Market Growth & Trends:

The global blood screening market is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.

Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Blood Screening Market Report Highlights:

  • The reagent segment accounted for the largest revenue share of around 73.0% in 2022 and is expected to grow at the fastest CAGR of 12.0% over the forecast period.
  • North America dominated the market and accounted for the largest revenue share of 39.0% in 2022 owing to the presence of key industry players, increased adoption of the blood screening process, stringent FDA regulations for transfusion, rising infectious disease prevalence, and greater patient affordability are responsible for maintaining its position during the forecast period.
  • Asia Pacific is expected to grow at the fastest CAGR of 13.5% over the forecast period owing to increasing awareness about blood donation, rising patient affordability, and the focus of key industry players on emerging countries in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Product
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Product outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
  • 3.5. Blood Screening Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Blood Screening Market: Technology Estimates & Trend Analysis

  • 4.1. Blood Screening Market: Key Takeaways
  • 4.2. Blood Screening Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Nucleic Acid Amplification (NAT)
    • 4.3.1. Nucleic acid amplification (NAT) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. ELISA
    • 4.4.1. ELISA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
    • 4.5.1. Chemiluminescence immunoassay (CLIA) and enzyme immunoassay (EIA) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Next-Generation Sequencing
    • 4.6.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Western Blotting
    • 4.7.1. Western blotting market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Screening Market: Product Estimates & Trend Analysis

  • 5.1. Blood Screening Market: Key Takeaways
  • 5.2. Blood Screening Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Reagent
    • 5.3.1. Reagent market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Instrument
    • 5.4.1. Instrument market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Blood Screening Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher Corporation (Beckman Coulter)
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bio-Rad Laboratories, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Hoffman-La Roche Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Grifols, S.A.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Ortho-Clinical Diagnostics, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Siemens Healthcare GmbH
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Thermo Fisher Scientific, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. SOFINA s.a (Biomerieux)
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 3 North America blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America blood screening market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 6 U.S. blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 7 Canada blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Canada blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 9 Europe blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Europe blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe blood screening market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Germany blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 15 UK blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 16 France blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 17 France blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 18 Italy blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Italy blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 20 Spain blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Spain blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 22 Sweden blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Sweden blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 24 Norway blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Norway blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Denmark blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific blood screening market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Japan blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 33 China blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 34 China blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 35 India blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 36 India blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Australia blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 39 Thailand blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Thailand blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 41 South Korea blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 42 South Korea blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Latin America blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America blood screening market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Brazil blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 48 Mexico blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Mexico blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Argentina blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa blood screening market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 56 South Africa blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 60 UAE blood screening market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait blood screening market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Kuwait blood screening market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Blood screening: Market outlook
  • Fig. 9 Blood screening: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Blood screening market driver impact
  • Fig. 15 Blood screening market restraint impact
  • Fig. 16 Blood screening market strategic initiatives analysis
  • Fig. 17 Blood screening market: Technology movement analysis
  • Fig. 18 Blood screening market: Technology outlook and key takeaways
  • Fig. 19 Nucleic acid amplification (NAT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Chemiluminescence immunoassay (CLIA) and enzyme immunoassay (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Next generation sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Western blotting market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Blood screening market: Product movement analysis
  • Fig. 25 Blood screening market: Product outlook and key takeaways
  • Fig. 26 Reagent market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global blood screening market: Regional movement analysis
  • Fig. 29 Global blood screening market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)